{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:41:18Z","timestamp":1791549678799,"version":"4.3.4"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","award":["420056"],"award-info":[{"award-number":["420056"]}],"id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Ministry of Health and Care Services | Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2012056"],"award-info":[{"award-number":["2012056"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Breast Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Ductal carcinoma in situ (DCIS) is a non-invasive type of breast cancer with highly variable potential of becoming invasive and affecting mortality. Currently, many patients with DCIS are overtreated due to the lack of specific biomarkers that distinguish low risk lesions from those with a higher risk of progression. In this study, we analyzed 57 pure DCIS and 313 invasive breast cancers (IBC) from different patients. Three levels of genomic data were obtained; gene expression, DNA methylation, and DNA copy number. We performed subtype stratified analyses and identified key differences between DCIS and IBC that suggest subtype specific progression. Prominent differences were found in tumors of the basal-like subtype: Basal-like DCIS were less proliferative and showed a higher degree of differentiation than basal-like IBC. Also,\n                    <jats:italic>core basal<\/jats:italic>\n                    tumors (characterized by high correlation to the basal-like centroid) were not identified amongst DCIS as opposed to IBC. At the copy number level, basal-like DCIS exhibited fewer copy number aberrations compared with basal-like IBC. An intriguing finding through analysis of the methylome was hypermethylation of multiple protocadherin genes in basal-like IBC compared with basal-like DCIS and normal tissue, possibly caused by long range epigenetic silencing. This points to silencing of cell adhesion-related genes specifically in IBC of the basal-like subtype. Our work confirms that subtype stratification is essential when studying progression from DCIS to IBC, and we provide evidence that basal-like DCIS show less aggressive characteristics and question the assumption that basal-like DCIS is a direct precursor of basal-like invasive breast cancer.\n                  <\/jats:p>","DOI":"10.1038\/s41523-020-0167-x","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T06:05:00Z","timestamp":1592373900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0999-1106","authenticated-orcid":false,"given":"Helga","family":"Bergholtz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonje G.","family":"Lien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3174-1656","authenticated-orcid":false,"given":"David M.","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnoldo","family":"Frigessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Oslo Breast Cancer Research Consortium (OSBREAC)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tone F.","family":"Bathen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin","family":"Borgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Lise","family":"B\u00f8rresen-Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Engebr\u00e5ten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ystein","family":"Garred","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gry Aarum","family":"Geitvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf Johan","family":"Hartmann-Johnsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solveig","family":"Hofvind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vessela N.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Langer\u00f8d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole Christian","family":"Lingj\u00e6rde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunhild Mari","family":"M\u00e6landsmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn","family":"Naume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege","family":"Russnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torill","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Schlichting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle Kristine","family":"Skjerven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Daidone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2683-0817","authenticated-orcid":false,"given":"J\u00f6rg","family":"Tost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"W\u00e4rnberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"S\u00f8rlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,17]]},"reference":[{"key":"167_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molonc.2013.07.005","volume":"7","author":"CF Cowell","year":"2013","unstructured":"Cowell, C. F. et al. Progression from ductal carcinoma in situ to invasive breast cancer: revisited. Mol. Oncol. 7, 1\u201311 (2013).","journal-title":"Mol. Oncol."},{"key":"167_CR2","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.3747\/co.25.3770","volume":"25","author":"JM Seely","year":"2018","unstructured":"Seely, J. M. & Alhassan, T. Screening for breast cancer in 2018\u2014what should we be doing today? Curr. Oncol. 25, S115\u2013S124 (2018).","journal-title":"Curr. Oncol."},{"key":"167_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/jnci\/djp482","volume":"102","author":"BA Virnig","year":"2010","unstructured":"Virnig, B. A., Tuttle, T. M., Shamliyan, T. & Kane, R. L. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J. Natl Cancer Inst. 102, 170\u2013178 (2010).","journal-title":"J. Natl Cancer Inst."},{"key":"167_CR4","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1093\/jnci\/94.20.1546","volume":"94","author":"VL Ernster","year":"2002","unstructured":"Ernster, V. L. et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J. Natl Cancer Inst. 94, 1546\u20131554 (2002).","journal-title":"J. Natl Cancer Inst."},{"key":"167_CR5","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1002\/cncr.21069","volume":"103","author":"ME Sanders","year":"2005","unstructured":"Sanders, M. E., Schuyler, P. A., Dupont, W. D. & Page, D. L. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 103, 2481\u20132484 (2005).","journal-title":"Cancer"},{"key":"167_CR6","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/1097-0142(19820215)49:4<751::AID-CNCR2820490426>3.0.CO;2-Y","volume":"49","author":"DL Page","year":"1982","unstructured":"Page, D. L., Dupont, W. D., Rogers, L. W. & Landenberger, M. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer 49, 751\u2013758 (1982).","journal-title":"Cancer"},{"key":"167_CR7","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1002\/1097-0142(19951001)76:7<1197::AID-CNCR2820760715>3.0.CO;2-0","volume":"76","author":"DL Page","year":"1995","unstructured":"Page, D. L., Dupont, W. D., Rogers, L. W., Jensen, R. A. & Schuyler, P. A. Continued local recurrence of carcinoma 15\u201325 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 76, 1197\u20131200 (1995).","journal-title":"Cancer"},{"key":"167_CR8","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/1097-0142(1984)54:4<612::AID-CNCR2820540403>3.0.CO;2-B","volume":"54","author":"M Nielsen","year":"1984","unstructured":"Nielsen, M., Jensen, J. & Andersen, J. Precancerous and cancerous breast lesions during lifetime and at autopsy. A study of 83 women. Cancer 54, 612\u2013615 (1984).","journal-title":"Cancer"},{"key":"167_CR9","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1002\/cncr.20979","volume":"103","author":"LC Collins","year":"2005","unstructured":"Collins, L. C. et al. Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses\u2019 Health Study. Cancer 103, 1778\u20131784 (2005).","journal-title":"Cancer"},{"key":"167_CR10","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1056\/NEJMra031301","volume":"350","author":"HJ Burstein","year":"2004","unstructured":"Burstein, H. J., Polyak, K., Wong, J. S., Lester, S. C. & Kaelin, C. M. Ductal carcinoma in situ of the breast. N. Engl. J. Med. 350, 1430\u20131441 (2004).","journal-title":"N. Engl. J. Med."},{"key":"167_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3389\/fonc.2017.00248","volume":"7","author":"KL Gorringe","year":"2017","unstructured":"Gorringe, K. L. & Fox, S. B. Ductal carcinoma in situ biology, biomarkers, and diagnosis. Front. Oncol. 7, 248 (2017).","journal-title":"Front. Oncol."},{"key":"167_CR12","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1016\/S1470-2045(13)70598-9","volume":"15","author":"LJ Esserman","year":"2014","unstructured":"Esserman, L. J. et al. Addressing overdiagnosis and overtreatment in cancer: a prescription for change. Lancet Oncol. 15, e234\u2013e242 (2014).","journal-title":"Lancet Oncol."},{"key":"167_CR13","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","volume":"1","author":"SA Narod","year":"2015","unstructured":"Narod, S. A., Iqbal, J., Giannakeas, V., Sopik, V. & Sun, P. Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol. 1, 888\u2013896 (2015).","journal-title":"JAMA Oncol."},{"key":"167_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.breast.2016.09.001","volume":"31","author":"EJ Groen","year":"2017","unstructured":"Groen, E. J. et al. Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS). Breast 31, 274\u2013283 (2017).","journal-title":"Breast"},{"key":"167_CR15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3389\/fonc.2017.00192","volume":"7","author":"Y Sagara","year":"2017","unstructured":"Sagara, Y., Julia, W., Golshan, M. & Toi, M. Paradigm shift toward reducing overtreatment of ductal carcinoma In situ of breast. Front. Oncol. 7, 192 (2017).","journal-title":"Front. Oncol."},{"key":"167_CR16","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1073\/pnas.0931261100","volume":"100","author":"X-J Ma","year":"2003","unstructured":"Ma, X.-J. et al. Gene expression profiles of human breast cancer progression. Proc. Natl Acad. Sci. USA 100, 5974\u20135979 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"167_CR17","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1158\/1078-0432.CCR-07-1465","volume":"14","author":"A Vincent-Salomon","year":"2008","unstructured":"Vincent-Salomon, A. et al. Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast. Clin. Cancer Res. 14, 1956\u20131965 (2008).","journal-title":"Clin. Cancer Res."},{"key":"167_CR18","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1158\/1078-0432.CCR-04-0165","volume":"10","author":"ES Hwang","year":"2004","unstructured":"Hwang, E. S. et al. Patterns of chromosomal alterations in breast ductal carcinoma in situ. Clin. Cancer Res. 10, 5160\u20135167 (2004).","journal-title":"Clin. Cancer Res."},{"key":"167_CR19","volume":"15","author":"T Fleischer","year":"2014","unstructured":"Fleischer, T. et al. Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis. Genome Biol. 15, 435 (2014).","journal-title":"Genome Biol."},{"key":"167_CR20","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T S\u00f8rlie","year":"2001","unstructured":"S\u00f8rlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA 98, 10869\u201310874 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"167_CR21","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.celrep.2016.06.051","volume":"16","author":"R Lesurf","year":"2016","unstructured":"Lesurf, R. et al. Molecular features of subtype-specific progression from ductal carcinoma in situ to invasive breast cancer. Cell Rep. 16, 1166\u20131179 (2016).","journal-title":"Cell Rep."},{"key":"167_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-011-1387-4","volume":"127","author":"SY Wang","year":"2011","unstructured":"Wang, S. Y., Shamliyan, T., Virnig, B. A. & Kane, R. Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Breast Cancer Res. Treat. 127, 1\u201314 (2011).","journal-title":"Breast Cancer Res. Treat."},{"key":"167_CR23","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1038\/bjc.2012.151","volume":"106","author":"MG Wallis","year":"2012","unstructured":"Wallis, M. G. et al. The effect of DCIS grade on rate, type and time to recurrence after 15 years of follow-up of screen-detected DCIS. Br. J. Cancer 106, 1611\u20131617 (2012).","journal-title":"Br. J. Cancer"},{"key":"167_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejca.2017.04.013","volume":"80","author":"T Onega","year":"2017","unstructured":"Onega, T. et al. The diagnostic challenge of low-grade ductal carcinoma in situ. Eur. J. Cancer 80, 39\u201347 (2017).","journal-title":"Eur. J. Cancer"},{"key":"167_CR25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s10549-015-3464-6","volume":"152","author":"E Rakovitch","year":"2015","unstructured":"Rakovitch, E. et al. A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone. Breast Cancer Res. Treat. 152, 389\u2013398 (2015).","journal-title":"Breast Cancer Res. Treat."},{"key":"167_CR26","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s41379-019-0204-1","volume":"32","author":"WM Hanna","year":"2019","unstructured":"Hanna, W. M. et al. Ductal carcinoma in situ of the breast: an update for the pathologist in the era of individualized risk assessment and tailored therapies. Mod. Pathol. 32, 896\u2013915 (2019).","journal-title":"Mod. Pathol."},{"key":"167_CR27","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","volume":"27","author":"J Parker","year":"2009","unstructured":"Parker, J. et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J. Clin. Oncol. 27, 1160\u20131167 (2009).","journal-title":"J. Clin. Oncol."},{"key":"167_CR28","doi-asserted-by":"publisher","first-page":"16910","DOI":"10.1073\/pnas.1009843107","volume":"107","author":"P Van Loo","year":"2010","unstructured":"Van Loo, P. et al. Allele-specific copy number analysis of tumors. Proc. Natl Acad. Sci. USA 107, 16910\u201316915 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"167_CR29","doi-asserted-by":"publisher","first-page":"6347","DOI":"10.1038\/onc.2008.218","volume":"27","author":"ER Motrescu","year":"2008","unstructured":"Motrescu, E. R. et al. Matrix metalloproteinase-11\/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions. Oncogene 27, 6347\u20136355 (2008).","journal-title":"Oncogene"},{"key":"167_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-7-134","volume":"7","author":"M Tischkowitz","year":"2007","unstructured":"Tischkowitz, M. et al. Use of immunohistochemical markers can refine prognosis in triple negative breast cancer. BMC Cancer 7, 134 (2007).","journal-title":"BMC Cancer"},{"key":"167_CR31","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis, C. et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346\u2013352 (2012).","journal-title":"Nature"},{"key":"167_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.yexcr.2017.03.001","volume":"358","author":"IS Gul","year":"2017","unstructured":"Gul, I. S., Hulpiau, P., Saeys, Y. & van Roy, F. Evolution and diversity of cadherins and catenins. Exp. Cell Res. 358, 3\u20139 (2017).","journal-title":"Exp. Cell Res."},{"key":"167_CR33","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.1242\/dev.090621","volume":"140","author":"WV Chen","year":"2013","unstructured":"Chen, W. V. & Maniatis, T. Clustered protocadherins. Development 140, 3297\u20133302 (2013).","journal-title":"Development"},{"key":"167_CR34","doi-asserted-by":"publisher","first-page":"8616","DOI":"10.1158\/0008-5472.CAN-08-1419","volume":"68","author":"P Novak","year":"2008","unstructured":"Novak, P. et al. Agglomerative epigenetic aberrations are a common event in human breast cancer. Cancer Res. 68, 8616\u20138625 (2008).","journal-title":"Cancer Res."},{"key":"167_CR35","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1038\/onc.2011.609","volume":"31","author":"AR Dallosso","year":"2012","unstructured":"Dallosso, A. R. et al. Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways. Oncogene 31, 4409\u20134419 (2012).","journal-title":"Oncogene"},{"key":"167_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/cam4.335","volume":"4","author":"KH Wang","year":"2015","unstructured":"Wang, K. H. et al. Global methylation silencing of clustered proto-cadherin genes in cervical cancer: Serving as diagnostic markers comparable to HPV. Cancer Med. 4, 43\u201355 (2015).","journal-title":"Cancer Med"},{"key":"167_CR37","doi-asserted-by":"publisher","unstructured":"Swanson, D. M., Lien, T., Bergholtz, H., S\u00f8rlie, T. & Frigessi, A. A Bayesian two-way latent structure model for genomic data integration reveals few pan-genomic cluster subtypes in a breast cancer cohort. Bioinformatics https:\/\/doi.org\/10.1093\/bioinformatics\/btz381 (2019).","DOI":"10.1093\/bioinformatics\/btz381"},{"key":"167_CR38","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.molonc.2013.08.008","volume":"7","author":"M Forn","year":"2013","unstructured":"Forn, M. et al. Long range epigenetic silencing is a trans-species mechanism that results in cancer specific deregulation by overriding the chromatin domains of normal cells. Mol. Oncol. 7, 1129\u20131141 (2013).","journal-title":"Mol. Oncol."},{"key":"167_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1000745","volume":"5","author":"AR Dallosso","year":"2009","unstructured":"Dallosso, A. R. et al. Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms\u2019 tumor. PLoS Genet. 5, e1000745 (2009).","journal-title":"PLoS Genet."},{"key":"167_CR40","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/gcc.20366","volume":"45","author":"A Bergamaschi","year":"2006","unstructured":"Bergamaschi, A. et al. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosom. Cancer 45, 1033\u20131040 (2006).","journal-title":"Genes Chromosom. Cancer"},{"key":"167_CR41","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cancergencyto.2009.03.017","volume":"193","author":"W Yu","year":"2009","unstructured":"Yu, W., Kanaan, Y., Baed, Y. K. & Gabrielson, E. Chromosomal changes in aggressive breast cancers with basal-like features. Cancer Genet. Cytogenet. 193, 29\u201337 (2009).","journal-title":"Cancer Genet. Cytogenet."},{"key":"167_CR42","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrc3647","volume":"14","author":"F Van Roy","year":"2014","unstructured":"Van Roy, F. Beyond E-cadherin: roles of other cadherin superfamily members in cancer. Nat. Rev. Cancer 14, 121\u2013134 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"167_CR43","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1242\/jcs.099697","volume":"125","author":"RYJ Huang","year":"2012","unstructured":"Huang, R. Y. J., Guilford, P. & Thiery, J. P. Early events in cell adhesion and polarity during epithelialmesenchymal transition. J. Cell Sci. 125, 4417\u20134422 (2012).","journal-title":"J. Cell Sci."},{"key":"167_CR44","doi-asserted-by":"crossref","unstructured":"Gheldof, A. & Berx, G. Cadherins and epithelial-to-mesenchymal transition. Prog. Mol. Biol. Transl. Sci. 116, 317\u2013336 (2013).","DOI":"10.1016\/B978-0-12-394311-8.00014-5"},{"key":"167_CR45","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1097\/PAS.0000000000001306","volume":"43","author":"LL Visser","year":"2019","unstructured":"Visser, L. L. et al. Discordant Marker expression between invasive breast carcinoma and corresponding synchronous and preceding DCIS. Am. J. Surg. Pathol. 43, 1574\u20131582 (2019).","journal-title":"Am. J. Surg. Pathol."},{"key":"167_CR46","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1158\/1078-0432.CCR-07-1658","volume":"14","author":"MCU Cheang","year":"2008","unstructured":"Cheang, M. C. U. et al. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin. Cancer Res. 14, 1368\u20131376 (2008).","journal-title":"Clin. Cancer Res."},{"key":"167_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13277-012-0602-1","volume":"34","author":"S Kurbel","year":"2013","unstructured":"Kurbel, S. In search of triple-negative DCIS: tumor-type dependent model of breast cancer progression from DCIS to the invasive cancer. Tumor Biol. 34, 1\u20137 (2013).","journal-title":"Tumor Biol."},{"key":"167_CR48","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10549-016-3862-4","volume":"158","author":"SC Doebar","year":"2016","unstructured":"Doebar, S. C. et al. Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study. Breast Cancer Res. Treat. 158, 179\u2013187 (2016).","journal-title":"Breast Cancer Res. Treat."},{"key":"167_CR49","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/modpathol.2010.200","volume":"24","author":"S Badve","year":"2011","unstructured":"Badve, S. et al. Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Mod. Pathol. 24, 157\u2013167 (2011).","journal-title":"Mod. Pathol."},{"key":"167_CR50","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/jnci\/djq099","volume":"102","author":"HG Welch","year":"2010","unstructured":"Welch, H. G. & Black, W. C. Overdiagnosis in cancer. J. Natl Cancer Inst. 102, 605\u2013613 (2010).","journal-title":"J. Natl Cancer Inst."},{"key":"167_CR51","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.molonc.2010.06.007","volume":"4","author":"AA Muggerud","year":"2010","unstructured":"Muggerud, A. A. et al. Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer. Mol. Oncol. 4, 357\u2013368 (2010).","journal-title":"Mol. Oncol."},{"key":"167_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-017-0812-y","volume":"19","author":"MR Aure","year":"2017","unstructured":"Aure, M. R. et al. Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome. Breast Cancer Res. 19, 44 (2017).","journal-title":"Breast Cancer Res."},{"key":"167_CR53","doi-asserted-by":"crossref","unstructured":"Aure, M. R. et al. Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome. Gene Expression Omnibus https:\/\/identifiers.org\/geo:GSE80999 (2017).","DOI":"10.1186\/s13058-017-0812-y"},{"key":"167_CR54","doi-asserted-by":"crossref","unstructured":"Fleischer, T. et al. Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis. Gene Expression Omnibus https:\/\/identifiers.org\/geo:GSE60185 (2014).","DOI":"10.1186\/s13059-014-0435-x"},{"key":"167_CR55","unstructured":"Lesurf, R. et al. Molecular features of subtype-specific progression from ductal carcinoma in situ to invasive breast cancer. Gene Expression Omnibus https:\/\/identifiers.org\/geo:GSE59248 (2016)."},{"key":"167_CR56","unstructured":"S\u00f8rlie, T. et al. Breast lesions assayed with Affymetrix SNP 6.0. European Genome-phenome Archive https:\/\/identifiers.org\/ega.dataset:EGAD00010000942 (2016)."},{"key":"167_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2632","volume":"12","author":"VD Haakensen","year":"2010","unstructured":"Haakensen, V. D. et al. Expression levels of uridine 5\u2019-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density. Breast Cancer Res. 12, R65 (2010).","journal-title":"Breast Cancer Res"},{"key":"167_CR58","unstructured":"S\u00f8rlie, T. et al. Gene expression. Milan samples. European Genome-phenome Archive https:\/\/identifiers.org\/ega.dataset:EGAD00010001864 (2020)."},{"key":"167_CR59","unstructured":"S\u00f8rlie, T. et al. DNA Methylation. Milan samples. European Genome-phenome Archive https:\/\/identifiers.org\/ega.dataset:EGAD00010001865 (2020)."},{"key":"167_CR60","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2217\/epi.12.21","volume":"4","author":"N Touleimat","year":"2012","unstructured":"Touleimat, N. & Tost, J. Complete pipeline for Infinium\u00ae Human Methylation 450K BeadChip data processing using subset quantile normalization for accurate DNA methylation estimation. Epigenomics 4, 325\u2013341 (2012).","journal-title":"Epigenomics"},{"key":"167_CR61","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/bjc.2013.496","volume":"109","author":"CS Wilhelm-Benartzi","year":"2013","unstructured":"Wilhelm-Benartzi, C. S. et al. Review of processing and analysis methods for DNA methylation array data. Br. J. Cancer 109, 1394\u20131402 (2013).","journal-title":"Br. J. Cancer"},{"key":"167_CR62","unstructured":"S\u00f8rlie, T. et al. DNA Copy Number. Milan samples. European Genome-phenome Archive https:\/\/identifiers.org\/ega.dataset:EGAD00010001863 (2020)."},{"key":"167_CR63","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1101\/gr.6861907","volume":"17","author":"K Wang","year":"2007","unstructured":"Wang, K. et al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res. 17, 1665\u20131674 (2007).","journal-title":"Genome Res."},{"key":"167_CR64","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nature02168","volume":"426","author":"The International HapMap Consortium.","year":"2003","unstructured":"The International HapMap Consortium. The international HapMap project. Nature 426, 789\u2013796 (2003).","journal-title":"Nature"},{"key":"167_CR65","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn556","volume":"36","author":"SJ Diskin","year":"2008","unstructured":"Diskin, S. J. et al. Adjustment of genomic waves in signal intensities from whole-genome SNP genotyping platforms. Nucleic Acids Res. 36, e126 (2008).","journal-title":"Nucleic Acids Res."},{"key":"167_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-13-591","volume":"13","author":"G Nilsen","year":"2012","unstructured":"Nilsen, G. et al. Copynumber: Efficient algorithms for single- and multi-track copy number segmentation. BMC Genomics 13, 591 (2012).","journal-title":"BMC Genomics"},{"key":"167_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-015-0520-4","volume":"17","author":"X Zhao","year":"2015","unstructured":"Zhao, X., R\u00f8dland, E. A., Tibshirani, R. & Plevritis, S. Molecular subtyping for clinically defined breast cancer subgroups. Breast Cancer Res. 17, 29 (2015).","journal-title":"Breast Cancer Res."},{"key":"167_CR68","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.1158\/1078-0432.CCR-10-1282","volume":"16","author":"TO Nielsen","year":"2010","unstructured":"Nielsen, T. O. et al. A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer. Clin. Cancer Res. 16, 5222\u20135232 (2010).","journal-title":"Clin. Cancer Res."},{"key":"167_CR69","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2635","volume":"12","author":"A Prat","year":"2010","unstructured":"Prat, A. et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res. 12, R68 (2010).","journal-title":"Breast Cancer Res"},{"key":"167_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).","journal-title":"Nat. Commun."},{"key":"167_CR71","unstructured":"R Core Team & R Foundation for Statistical Computing. R: a language and environment for statistical computing. (2017)."},{"key":"167_CR72","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu, Z., Eils, R. & Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32, 2847\u20132849 (2016).","journal-title":"Bioinformatics"},{"key":"167_CR73","doi-asserted-by":"crossref","unstructured":"Wickham, H. Ggplot2: elegrant graphics for data analysis. (2016).","DOI":"10.1007\/978-3-319-24277-4"},{"key":"167_CR74","doi-asserted-by":"publisher","unstructured":"Bergholtz, H. et al. Metadata supporting the published article: Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions. figshare https:\/\/doi.org\/10.6084\/m9.figshare.12293102 (2020).","DOI":"10.6084\/m9.figshare.12293102"}],"container-title":["npj Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41523-020-0167-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-020-0167-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-020-0167-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T21:49:46Z","timestamp":1670276986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41523-020-0167-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["167"],"URL":"https:\/\/doi.org\/10.1038\/s41523-020-0167-x","relation":{},"ISSN":["2374-4677"],"issn-type":[{"value":"2374-4677","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,17]]},"assertion":[{"value":"20 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}